XENE
Xenon Pharmaceuticals Inc.
Key Financials
Net Income
$-345910000
↓ 47.6%
Operating Cash Flow
$-279118000.00
↓ 53.9%
Total Assets
$633.2M
↓ 20.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/13/2026 | View on SEC |
| 144 | 8/13/2026 | View on SEC |
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| SCHEDULE 13G/A | 8/7/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| SCHEDULE 13G/A | 8/6/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 144 | 6/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | XENE |
| Company Name | Xenon Pharmaceuticals Inc. |
| CIK | 1582313 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A1 |
| Phone | (604) 484-3300 |